Post by seanismorris on May 30, 2014 22:01:26 GMT -5
Interesting quote:
In a panel, Kelly Close described her experience on one of these systems: “I can’t even begin to speak about how amazing it was and I’ve been following the artificial pancreas for a long time. There are three big things stopping it: the sensors aren’t good enough, the algorithms are good enough, and the insulin is too slow.” She went on to explain that the sensors and algorithms are allowing the workarounds that insulin is too slow. She emphasized the transformative experience on the artificial pancreas: “I felt smarter, I felt nicer. You have so much less noise in your head when you’re not trying to manage this incredibly dangerous drug called insulin. The power of glucagon was also really cool to see. Not having any hypo, but having no fear of hypo, and no eating due to hypoglycemia.”
As we know very well as Mannkind investors "insulin is too slow" what is interesting is that she thinks the closed loop insulin pumps offers a work around. Personally, I don't think that is the case. I think artificial pancreases are the future, but in conjunction with Afrezza.
www.diabetesdaily.com/voices/2013/07/the-latest-diabetes-treatments/
FYI: Mannkind is still listed as having a booth at the 74th ADA (in June)...
In a panel, Kelly Close described her experience on one of these systems: “I can’t even begin to speak about how amazing it was and I’ve been following the artificial pancreas for a long time. There are three big things stopping it: the sensors aren’t good enough, the algorithms are good enough, and the insulin is too slow.” She went on to explain that the sensors and algorithms are allowing the workarounds that insulin is too slow. She emphasized the transformative experience on the artificial pancreas: “I felt smarter, I felt nicer. You have so much less noise in your head when you’re not trying to manage this incredibly dangerous drug called insulin. The power of glucagon was also really cool to see. Not having any hypo, but having no fear of hypo, and no eating due to hypoglycemia.”
As we know very well as Mannkind investors "insulin is too slow" what is interesting is that she thinks the closed loop insulin pumps offers a work around. Personally, I don't think that is the case. I think artificial pancreases are the future, but in conjunction with Afrezza.
www.diabetesdaily.com/voices/2013/07/the-latest-diabetes-treatments/
FYI: Mannkind is still listed as having a booth at the 74th ADA (in June)...